Information
-
Trademark
-
86605899
-
Serial Number
86605899
-
Registration Number
5038910
-
International Classifications
-
Filing Date
April 22, 2015
9 years ago
-
Registration Date
September 13, 2016
8 years ago
-
Transaction Date
May 02, 2023
a year ago
-
Status Date
March 24, 2023
a year ago
-
Published for Opposition Date
June 28, 2016
8 years ago
-
Location Date
September 13, 2016
8 years ago
-
Status Code
710
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
LEASER, ANDREW C
-
Attorney Docket Number
ZIMM_TM001
Attorney Name
Leonard P. Linardakis
Law Office Assigned Location Code
M80
-
Owners
Mark Drawing Code
4000
Mark Identification
MEDIGENE IMMUNOTHERAPIES
Case File Statements
- GS0051: Medicines for humans and animals for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, medicated serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays for testing of bodily fluids for use in disease detection, namely, tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, all prepared by means of molecular biology, genetic engineering or biotechnological methods; substances for medical diagnosis purposes, namely, proteins, nucleic acids, cell products, protein conjugates, peptides, enzymes and enzyme preparations, particularly antibodies and T cell proteins; T cells, dendritic cells, and other cells of the immune system, viruses, and virus-like particles, all for medical purposes; liposomes for medical purposes; plant extracts for medical purposes; low molecular active ingredients, namely, medicines for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, adjuvants, serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays that test for the presence of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, autoimmune diseases and immune therapy
- PM0001: MEDIGENE IMMUNO THERAPIES
- GS0451: Licensing of intellectual property, including trademarks and patents in the field of biotechnology, pharmacy, and medicine
- GS0441: Medical analyses and medical consultancy in the context of the treatment of single persons, particularly in the field of tumor precursors, benign and malignant tumor diseases, autoimmune diseases and immunotherapy
- D10000: "IMMUNOTHERAPIES"
- GS0421: Services of a molecular biology or biotechnology laboratory, particularly research and development work in the field of human medical and veterinary medical diagnosis and therapy by means of molecular biology, genetic engineering or biotechnological methods as well as in the field of screening for pharmaceutically active compounds; design and development of test methods and test kits in the field of biotechnology and medicine
Case File Event Statements
-
3/24/2023 - a year ago
32 - CANCELLED SEC. 8 (6-YR)
Type: C8..
-
9/13/2021 - 3 years ago
31 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1
-
9/13/2016 - 8 years ago
30 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
6/28/2016 - 8 years ago
29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/28/2016 - 8 years ago
28 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
6/8/2016 - 8 years ago
27 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/23/2016 - 8 years ago
26 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
5/13/2016 - 8 years ago
25 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/12/2016 - 8 years ago
24 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
5/12/2016 - 8 years ago
23 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
5/6/2016 - 8 years ago
22 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
5/6/2016 - 8 years ago
21 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
5/6/2016 - 8 years ago
20 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
12/17/2015 - 9 years ago
19 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/9/2015 - 9 years ago
18 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
11/9/2015 - 9 years ago
17 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
11/9/2015 - 9 years ago
16 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
10/21/2015 - 9 years ago
15 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
10/21/2015 - 9 years ago
14 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
10/14/2015 - 9 years ago
13 - ASSIGNED TO LIE
Type: ALIE
-
9/23/2015 - 9 years ago
12 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Type: ERSI
-
8/7/2015 - 9 years ago
11 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
8/7/2015 - 9 years ago
10 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
8/7/2015 - 9 years ago
9 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
8/7/2015 - 9 years ago
8 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
8/7/2015 - 9 years ago
7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
8/7/2015 - 9 years ago
6 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
8/7/2015 - 9 years ago
5 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
7/31/2015 - 9 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
5/2/2015 - 9 years ago
3 - NOTICE OF PSEUDO MARK E-MAILED
Type: MPMK
-
5/1/2015 - 9 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
4/25/2015 - 9 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
